The next frontier for innovation,
research, clinical trials, and state-of-the art treatment.

Our history of research and innovation has resulted in many of the diagnostic and therapeutic techniques currently used around the world to treat cancer and blood disorders. Today, we continue to stand among the world’s leaders in many innovative approaches.

Our Researchers

at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

A. Thomas Look Lab

Our laboratory seeks to elucidate the molecular pathogenesis of human leukemias and solid tumors using both a cell culture model and a zebrafish animal model.

Agarwal Lab

Certain genetic disorders cause widespread disease in the body, but the principle reason for illness and death in early childhood is failure of the blood system. We would like to…

Bahl Lab

We are leveraging cutting-edge protein engineering methods to create genetically-encodable macromolecules with novel function. The combination of computational design and directed evolution is unlocking new proteins with capabilities never before…

Bauer Lab

The laboratory studies the genetic determinants of blood cell ontogeny and disease. The blood system recapitulates fundamental biologic activities, such as renewal/differentiation, regeneration/homeostasis, and development/aging. We use molecular genetic, biochemical,…

Cantor Lab

The broad interests of the Cantor Laboratory are to elucidate the gene regulatory mechanisms involved in normal blood cell development and to understand how their dysregulation leads to certain human…

Carla Kim Lab

The broad interest of the Kim Lab is to characterize the biology of stem cells in normal lung and lung cancer. Numerous lung diseases such as cystic fibrosis or chronic…

Crompton Laboratory

Dr. Crompton is a physician-scientist conducting translational research in pediatric solid tumors. His laboratory program focuses on utilizing proteomic and genomic approaches to expand our understanding of cancer biology and…

Daley Lab

Our laboratory seeks a better understanding of the biology, pathology, and clinical utility of hematopoietic and pluripotent stem cells and of the role of various tissue stem cells in development…

Kean Lab

Dr. Kean’s laboratory is working to solve the mystery of immune recognition and immune tolerance. Immune recognition is the process by which the immune system differentiates between healthy cells and…

Knoechel Lab

Our research efforts focus on identifying epigenetic dependencies in pediatric tumors with a particular focus on high risk pediatric leukemias and sarcomas. Defects in chromatin and aberrant epigenetic regulation and…

Center for Platelet Research Studies

The Center for Platelet Research Studies is an internationally recognized multidisciplinary center for the study of platelet function by state-of-the-art methods. The Center undertakes basic, translational, and clinical research, including…

Orkin Lab

The Orkin laboratory focuses on stem cell biology, particularly the development and function of the blood system, the relationship between cancer and stem cells, and the mechanisms responsible for self-renewal…

Sankaran Laboratory

The Sankaran laboratory uses human genetic studies to gain insight into normal hematopoiesis and how this process is perturbed in disease. Our studies are relevant to numerous blood diseases, including…

Shimamura Lab

The broad interest of the Shimamura lab is the genetic and molecular mechanisms regulating hematopoiesis and clonal evolution to MDS and leukemia. The Shimamura lab studies inherited bone marrow failure…

The Alejandro Gutierrez Lab

Our laboratory’s primary interest lies in unraveling the molecular pathogenesis of human cancer, with a focus on discovery of novel therapeutic targets in chemoresistant human cancers. Our approach combines analysis…

The Bandopadhayay Lab

The Bandopadhayay Lab at Dana-Farber Cancer Institute focuses on: Identifying genomic and epigenetic drivers of pediatric brain tumors, characterizing resistance mechanisms of pediatric brain tumors, and developing more effective treatments…

Williams Laboratory

The Wolfe Lab

Walensky Laboratory

The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer. In particular, the lab’s studies emphasize the chemical, structural, and cell biology of the…

Weinstock Laboratory

The Weinstock Laboratory uses a range of approaches at the intersection of genetics, DNA repair, and mouse modeling to address the ontogeny, pathogenesis, and therapeutic targeting of lymphoid neoplasms.

A. Thomas Look Lab

Our laboratory seeks to elucidate the molecular pathogenesis of human leukemias and solid tumors using both a cell culture model and a zebrafish animal model.
Read More

Agarwal Lab

Certain genetic disorders cause widespread disease in the body, but the principle reason for illness and death in early childhood is failure of the blood system. We would like to…
Read More

Bahl Lab

Bauer Lab

Cantor Lab

Carla Kim Lab

The broad interest of the Kim Lab is to characterize the biology of stem cells in normal lung and lung cancer. Numerous lung diseases such as cystic fibrosis or chronic…
Read More

Crompton Laboratory

Daley Lab

Our laboratory seeks a better understanding of the biology, pathology, and clinical utility of hematopoietic and pluripotent stem cells and of the role of various tissue stem cells in development…
Read More

Kean Lab

Knoechel Lab

Center for Platelet Research Studies

Orkin Lab

Our Researchers in the News

Gene therapy trial gives Coopersville toddler second chance at life

Colton was born healthy almost two years ago, but his fraternal twin brother, Levi, was not. The Michigan toddler had severe combined immune deficiency – “bubble boy” disease – discovered through newborn screening, Fox 17 reports from Grand Rapids.

New Chief Scientific Officer at Boston Children’s Hospital

Boston Children’s Hospital has established a new executive role to focus on research, the hospital announced. Dr. David Williams, who serves as chief of hematology and oncology and director of clinical and translational research at Boston Children’s Hospital, will serve as chief scientific officer.

Childhood cancer deaths: Brain cancer overtakes leukemia as top cause

Leukemia is no longer the No. 1 cause of cancer deaths in children, but brain cancer has taken it's place, according to a new report.